Delivery Order SPE2DB22D3401-SPE2DB25FT4MQ
Award Date
6/11/25
Potential Completion Date
6/12/25
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract is for the delivery of OXCARBAZEPINE ER 150 MG TABLET 100S, with a ceiling value of $2,028.63 and a performance period that runs through May 16, 2025. The contract is a firm fixed price, non-set-aside award. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Oxcarbazepine 600 mg tablets, a neurological medication, with a ceiling value of $1,792.41 and a performance period through June 2025. The contract is not set aside and is a firm fixed-price type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4566734673 OXCARBAZEPINE ER 600 MG TABLET 100S. The contract has a ceiling value of $5,945.20 and an ultimate completion date of December 17, 2024. This award is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, with ID SPE2DB22D1202|SPE2DB25FUJK4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,482.78 firm fixed-price delivery order is for the supply of 4566420572 - OXCARBAZEPINE 300 MG TABLET 100S. The contract has an ultimate completion date of November 14, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $6,261.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100-count bottles of OXCARBAZEPINE ER 600 MG tablets, a generic medication used to treat seizures. The contract has a completion date of January 31, 2025 and is a Firm Fixed Price Delivery Order contract type. This award is part of a larger Indefinite Delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The order is for the supply of 250 milliliters of OXCARBAZEPINE 300 milligram/5 milliliter suspension, with a potential value of $6,125.58. The contract does not have a set-aside designation and is scheduled for completion by December 20, 2023. AmerisourceBergen Drug Corp,...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FQK15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,012,982 tablets of Oxcarbazepine ER 600 mg, a neurological medication, with a ceiling value of $2,154.48. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 24, 2025. The contract is not set aside and was open to full and open...
This federal contract award, with a ceiling value of $2,176.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product OXCARBAZEPINE 300 MG/5 ML SUSP 250ML. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The contract, valued at $3,268.33, is for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of October 30, 2023 and was awarded on October 27, 2022. This contract is not...
This is a Delivery Order (DO) federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, is for the delivery of OXCARBAZEPINE 300 MG/5 ML SUSP 250ML, a neurological medication. The contract has a ceiling value of $3,523.92 and a completion date of May 21, 2025. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of...